Sara Elizabeth Townsley

Array ( [id] => 8264696 [patent_doc_number] => 20120164122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'PHYTOESTROGENIC FORMULATIONS FOR ALLEVIATION OR PREVENTION OF NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 13/362825 [patent_app_country] => US [patent_app_date] => 2012-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15359 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13362825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9162142 [patent_doc_number] => 20130310419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-21 [patent_title] => 'PYRROLE DERIVATIVES USED AS MODULATORS OF ALPHA7 NACHR' [patent_app_type] => utility [patent_app_number] => 13/983362 [patent_app_country] => US [patent_app_date] => 2012-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22111 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13983362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9135678 [patent_doc_number] => 20130296393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'METHOD FOR CONTROLLING CLUBROOT' [patent_app_type] => utility [patent_app_number] => 13/978666 [patent_app_country] => US [patent_app_date] => 2012-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7277 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11304722 [patent_doc_number] => 09512109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-06 [patent_title] => 'Agonists that enhance binding of integrin-expressing cells to integrin receptors' [patent_app_type] => utility [patent_app_number] => 13/885537 [patent_app_country] => US [patent_app_date] => 2011-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37629 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1041 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13885537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784709 [patent_doc_number] => 20120046265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'USE OF ERGOSTA-7,22-DIEN-3beta-OL IN THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/283619 [patent_app_country] => US [patent_app_date] => 2011-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4390 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046265.pdf [firstpage_image] =>[orig_patent_app_number] => 13283619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10876560 [patent_doc_number] => 08901347 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-12-02 [patent_title] => 'Absorbable polyurethanes and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/275902 [patent_app_country] => US [patent_app_date] => 2011-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15690 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13275902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9192089 [patent_doc_number] => 20130331404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'Methods and Compositions for Inhibition of Polymerase' [patent_app_type] => utility [patent_app_number] => 13/879110 [patent_app_country] => US [patent_app_date] => 2011-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18725 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8140931 [patent_doc_number] => 20120095016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'THERAPEUTIC 5,6,5-TRICYCLIC ANALOGS' [patent_app_type] => utility [patent_app_number] => 13/270982 [patent_app_country] => US [patent_app_date] => 2011-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16814 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20120095016.pdf [firstpage_image] =>[orig_patent_app_number] => 13270982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7731362 [patent_doc_number] => 20120014880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'METHOD FOR THE PREVENTION AND TREATMENT OF ESSENTIAL TREMOR BY REGULATING alpha1G T-TYPE CALCIUM CHANNEL OR BY T-TYPE CALCIUM CHANNEL BLOCKERS' [patent_app_type] => utility [patent_app_number] => 13/243325 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4117 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20120014880.pdf [firstpage_image] =>[orig_patent_app_number] => 13243325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720958 [patent_doc_number] => 20120010293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF MOOD DISORDERS, SLEEP DISORDERS, OR ATTENTION DEFICIT DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/237178 [patent_app_country] => US [patent_app_date] => 2011-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19793 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010293.pdf [firstpage_image] =>[orig_patent_app_number] => 13237178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8095825 [patent_doc_number] => 20120083524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'Oral Composition Comprising DHA and Genistein for Enhancing Skin Properties' [patent_app_type] => utility [patent_app_number] => 13/236358 [patent_app_country] => US [patent_app_date] => 2011-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7073 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20120083524.pdf [firstpage_image] =>[orig_patent_app_number] => 13236358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580886 [patent_doc_number] => 20110294769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'NITROOXY DERIVATIVES OF GLUCOCORTICOIDS' [patent_app_type] => utility [patent_app_number] => 13/207231 [patent_app_country] => US [patent_app_date] => 2011-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10728 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294769.pdf [firstpage_image] =>[orig_patent_app_number] => 13207231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817376 [patent_doc_number] => 20120063996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'NOVEL NIMESULIDE COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/193545 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16612 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20120063996.pdf [firstpage_image] =>[orig_patent_app_number] => 13193545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754590 [patent_doc_number] => 20120027752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'METHODS AND COMPOUNDS FOR TREATING PARAMYXOVIRIDAE VIRUS INFECTIONS' [patent_app_type] => utility [patent_app_number] => 13/189373 [patent_app_country] => US [patent_app_date] => 2011-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36857 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027752.pdf [firstpage_image] =>[orig_patent_app_number] => 13189373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587313 [patent_doc_number] => 20110281823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'Pharmaceutical preparation containing an angiotensin II Receptor antagonist, a calcium channel blocker and polyvinyl alcohol' [patent_app_type] => utility [patent_app_number] => 13/135961 [patent_app_country] => US [patent_app_date] => 2011-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6774 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281823.pdf [firstpage_image] =>[orig_patent_app_number] => 13135961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8374957 [patent_doc_number] => 08257745 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-04 [patent_title] => 'Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs' [patent_app_type] => utility [patent_app_number] => 13/186108 [patent_app_country] => US [patent_app_date] => 2011-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3035 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13186108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8171387 [patent_doc_number] => 20120107385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'METHOD OF TREATING CONDITIONS ASSOCIATED WITH OVERACTIVE BLADDER' [patent_app_type] => utility [patent_app_number] => 13/166302 [patent_app_country] => US [patent_app_date] => 2011-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22273 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107385.pdf [firstpage_image] =>[orig_patent_app_number] => 13166302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7576811 [patent_doc_number] => 20110290693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'Abnormal Scar Therapy' [patent_app_type] => utility [patent_app_number] => 13/118549 [patent_app_country] => US [patent_app_date] => 2011-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4827 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0290/20110290693.pdf [firstpage_image] =>[orig_patent_app_number] => 13118549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7568116 [patent_doc_number] => 20110288179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'BIMATOPROST CRYSTALLINE FORM I' [patent_app_type] => utility [patent_app_number] => 13/113136 [patent_app_country] => US [patent_app_date] => 2011-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12261 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288179.pdf [firstpage_image] =>[orig_patent_app_number] => 13113136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8697867 [patent_doc_number] => 20130059876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'LIQUID NASAL SPRAY CONTAINING LOW-DOSE NALTREXONE' [patent_app_type] => utility [patent_app_number] => 13/698128 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2401 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13698128 [rel_patent_id] =>[rel_patent_doc_number] =>)